<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jang JY</submitter><funding>National Research Foundation of Korea</funding><pagination>E96</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6337620</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(1)</volume><pubmed_abstract>We investigated the antitumor activity and action mechanism of MHY440 in AGS human gastric cancer cells. MHY440 inhibited topoisomerase (Topo) Ι activity and was associated with a DNA damage response signaling pathway. It exhibited a stronger anti-proliferative effect on AGS cells relative to Hs27 human foreskin fibroblast cells, and this effect was both time- and concentration-dependent. MHY440 also increased cell arrest in the G2/M phase by decreasing cyclin B1, Cdc2, and Cdc25c, and upregulating p53 and p73. MHY440 induced AGS cell apoptosis through the upregulation of Fas-L, Fas, and Bax as well as the proteolysis of BH3 interacting-domain death agonist and poly(ADP-ribose) polymerase. It also contributed to the loss of mitochondrial membrane potential. The apoptotic cell death induced</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pubmed_title>MHY440, a Novel Topoisomerase Ι Inhibitor, Induces Cell Cycle Arrest and Apoptosis via a ROS-Dependent DNA Damage Signaling Pathway in AGS Human Gastric Cancer Cells.</pubmed_title><pmcid>PMC6337620</pmcid><funding_grant_id>2009-0083538</funding_grant_id><funding_grant_id>2018R1D1A1B07044648</funding_grant_id><pubmed_authors>Moon HR</pubmed_authors><pubmed_authors>Kim ND</pubmed_authors><pubmed_authors>Chung HY</pubmed_authors><pubmed_authors>Kang YJ</pubmed_authors><pubmed_authors>Kang D</pubmed_authors><pubmed_authors>Sung B</pubmed_authors><pubmed_authors>Kim MJ</pubmed_authors><pubmed_authors>Park C</pubmed_authors><pubmed_authors>Jang JY</pubmed_authors></additional><is_claimable>false</is_claimable><name>MHY440, a Novel Topoisomerase Ι Inhibitor, Induces Cell Cycle Arrest and Apoptosis via a ROS-Dependent DNA Damage Signaling Pathway in AGS Human Gastric Cancer Cells.</name><description>We investigated the antitumor activity and action mechanism of MHY440 in AGS human gastric cancer cells. MHY440 inhibited topoisomerase (Topo) Ι activity and was associated with a DNA damage response signaling pathway. It exhibited a stronger anti-proliferative effect on AGS cells relative to Hs27 human foreskin fibroblast cells, and this effect was both time- and concentration-dependent. MHY440 also increased cell arrest in the G2/M phase by decreasing cyclin B1, Cdc2, and Cdc25c, and upregulating p53 and p73. MHY440 induced AGS cell apoptosis through the upregulation of Fas-L, Fas, and Bax as well as the proteolysis of BH3 interacting-domain death agonist and poly(ADP-ribose) polymerase. It also contributed to the loss of mitochondrial membrane potential. The apoptotic cell death induced</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Dec</publication><modification>2026-05-05T06:37:34.483Z</modification><creation>2019-03-26T22:40:59Z</creation></dates><accession>S-EPMC6337620</accession><cross_references><pubmed>30597845</pubmed><doi>10.3390/molecules24010096</doi></cross_references></HashMap>